Largest review of its kind associates anti-inflammatory drugs with reduced breast cancer risk

Analysis of data from 38 studies that enrolled more than 2.7 million women – the largest of its kind – by researchers at the University of British Columbia, Vancouver Coastal Health Research Institute, and the University of Santiago de Compostela reveals that regular use of Non Steroidal Anti-Inflammatory Drugs (NSAIDs) is associated with a 12 per cent relative risk reduction in breast cancer compared to non-users.

If you want to include this story in your blog, copy and paste this formatted text:

<p><a href="http://www.physorg.com/news142616691.html">Largest review of its kind associates anti-inflammatory drugs with reduced breast cancer risk</a></p> <p>Analysis of data from 38 studies that enrolled more than 2.7 million women – the largest of its kind – by researchers at the University of British Columbia, Vancouver Coastal Health Research Institute, and the University of Santiago de Compostela reveals that regular use of Non Steroidal Anti-Inflammatory Drugs (NSAIDs) is associated with a 12 per cent relative risk reduction in breast cancer compared to non-users.</p>